About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72808 record(s)
Req # A-2019-001700
Adverse Reaction Report (AER) for CANCIDAS. Report number: 000673581. AERs for COZAAR: E2B_00343874, E2B_00006383, E2B_00780183. AERs for CUBICIN: 000671530, 000675609, 000678055, 000681798, E2B_00811328. AERs for ELOCOM: 000665808, 000668329. AER…Organization: Health Canada
February 2021
Req # A-2019-001730
Adverse Reaction Reports (AERs) for FEIBA. Report numbers: 000728925, 000728954, 000728956, 000729683.Organization: Health Canada
February 2021
Req # A-2020-000095
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02760068, E2B_02709373, E2B_02670994, E2B_02680663, 732557, E2B_02817540, E2B_02818125, E2B_02819943,E2B_02823147, E2B_02826161, E2B_02826720, E2B_02827568,…Organization: Health Canada
February 2021
Req # A-2020-000215
Adverse Reaction Reports (AERs) for FOSAMAX. Report numbers: 000665829, 000667215, E2B_00483641, E2B_00498826, E2B_00500827,E2B_00498902, E2B_00644065, E2B_00506460, E2B_00785350, E2B_00786948,E2B_00786970, E2B_00791529, E2B_00792724, E2B_00803504,…Organization: Health Canada
February 2021
Req # A-2020-000258
Adverse Reaction Reports (AERs) for METRONIDAZOLE. Report numbers: 000729472, 000730330, E2B_02692107, E2B_02757278, E2B_02773208, E2B_02776199,E2B_02795025, E2B_02796705, E2B_02800387, E2B_02801830, E2B_02805372,E2B_02806927, E2B_02808608,…Organization: Health Canada
February 2021
Req # A-2020-000382
Adverse Drug Reaction (ADR). Report number: E2B_02755588.Organization: Health Canada
February 2021
Req # A-2020-000436
Adverse Drug Reaction (ADR) for botulinum toxin. Report number: E2B_03052678.Organization: Health Canada
February 2021
Req # A-2020-000437
Adverse Drug Reaction (ADR) for Botulinum toxin. Report number: E2B_03068595.Organization: Health Canada
February 2021
Req # A-2020-000438
Adverse Drug Reaction (ADR) for botulinum toxin. Report number: E2B_03073853.Organization: Health Canada
February 2021
Req # A-2020-000458
Adverse Drug Reaction (ADR) for Botulinum toxin. Report number: E2B_03022818.Organization: Health Canada
February 2021